Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy Caucasians

Summary

This is a phase 1, randomized, double-blind, placebo-controlled study. The objective of this study is to evaluate the safety, tolerability, and PK profile of HRS-9231 injection following a single dose in healthy Caucasian participants.

Timeline

Start

2024-08-21

Primary completion

2024-09-29

Completion

2024-11-27

Drugs

Indications